Elicio Therapeutics Inc (ELTX)
9.38
-1.02
(-9.81%)
USD |
NASDAQ |
May 16, 16:00
9.35
-0.03
(-0.32%)
After-Hours: 20:00
Elicio Therapeutics Total Liabilities (Quarterly): 15.77M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 15.77M |
| September 30, 2023 | 17.70M |
| June 30, 2023 | 14.06M |
| Date | Value |
|---|---|
| December 31, 2022 | 124.81M |
| March 31, 2021 | 73.99M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
14.06M
Minimum
Jun 2023
124.81M
Maximum
Dec 2022
49.27M
Average
17.70M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Immuneering Corp | 9.260M |
| Outlook Therapeutics Inc | 46.03M |
| Amylyx Pharmaceuticals Inc | 93.02M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 24.94M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.15M |
| Shareholders Equity (Quarterly) | 11.37M |